Sitagliptin Tablet
Product Images NDC 70771-1791

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 70771-1791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 01)

Chemical structure of sitagliptin, showing its molecular arrangement including trifluoromethyl and piperazine groups as part of the oral tablet drug. This diagram illustrates the compound's atomic connectivity used in Sitagliptin formulations by Zydus Lifesciences Limited.*

FDA Label Image

Image (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 02)

This line graph depicts the least squares mean change from baseline over a 24-week period in a clinical study comparing placebo, Metformin (1000 mg b.i.d. and 500 mg b.i.d.), Sitagliptin 100 mg q.d., and combinations of Sitagliptin 50 mg b.i.d. with Metformin (500 mg b.i.d. and 1000 mg b.i.d.). The x-axis represents weeks, and the y-axis shows LS mean change from baseline.*

FDA Label Image

Image (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 03)

A line graph showing LS mean change from baseline over 52 weeks. The x-axis represents time in weeks from 0 to 52, and the y-axis shows the LS mean change ranging approximately from 0.0 to -1.5. Two lines are plotted, indicating changes over different conditions or groups as time progresses, with the lowest change around weeks 18 to 30 before a slight increase towards week 52.*

FDA Label Image

25 mg Label (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 04)

Label for Sitagliptin Tablets 25 mg oral tablets by Zydus Lifesciences Limited. The package contains 90 tablets and includes instructions to dispense the enclosed Medication Guide and to use within 3 months of opening. Storage and safety information is provided along with the NDC number 70771-1790-9.*

FDA Label Image

50 mg Label (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 05)

Label for Sitagliptin Tablets 50 mg by Zydus Lifesciences Limited. The label includes the drug name, strength, a barcode, and instructions to dispense the enclosed Medication Guide. It indicates a package size of 90 tablets for oral use, labeled as Rx only. Storage and usage warnings are prominently displayed, including child resistance and moisture protection guidance.*

FDA Label Image

100 mg Label (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 06)

Sitagliptin 100 mg tablets label from Zydus Lifesciences Limited. The prescription oral tablet package contains 90 tablets. The label includes storage instructions, a barcode, NDC 70771-1792-9, and advises dispensing the enclosed Medication Guide to patients. It emphasizes using the product within 3 months of opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.